Synthetic vs Collagen Dural Substitutes: An Even-Handed Buyer's Guide

Synthetic and collagen dural substitutes are both established options, and neither is the right answer for every surgeon or every case. Collagen grafts are biologically derived scaffolds intended to be gradually resorbed; synthetic substitutes are engineered polymers, some permanent and some resorbable. A buyer's task is to understand the differences and support the options surgeons actually need.

This guide is written for hospital supply-chain teams, value-analysis committees and distributors who need a fair comparison. DESU manufactures collagen dural grafts, so we have a perspective; we have tried to set it aside and describe both categories honestly. A buyer who hears a balanced comparison is better placed to make a decision that holds up with surgeons.

What are the main categories of dural substitute?

Before comparing, it helps to name the categories clearly. Surgeons use broadly four kinds of material to repair or replace dura:

• Autologous tissue, taken from the patient during the operation, such as pericranium, temporalis fascia or fascia lata.
• Collagen-based substitutes, made from purified animal collagen and processed into sheets or matrices.
• Synthetic non-resorbable substitutes, made from polymers designed to remain in place permanently.
• Synthetic resorbable substitutes, made from polymers designed to break down over time.

Allograft dura from human donors was used widely in the past. Its association with transmission of Creutzfeldt-Jakob disease led many countries to abandon it, and it plays little role in current practice. Autologous tissue is discussed in a separate article; this one focuses on the comparison buyers ask about most often: synthetic or collagen.

How do synthetic and collagen substitutes differ?

The differences fall into a few areas. The table below summarizes them in general terms. Individual products within each category vary, so every product should be judged on its own documentation.

This is the frame a committee needs. It shows that the choice is not between "natural and good" and "artificial and bad", or the reverse, but between two families of materials with different properties and different documentation.

Why do surgeons prefer one or the other?

Reasons given for collagen

Surgeons who choose collagen often cite familiarity with the material, the concept of a scaffold that the body gradually replaces with its own tissue, and the handling of collagen membranes. Collagen has a long history in neurosurgery, and many surgeons trained with it.

Collagen grafts are also available in both sutured and onlay formats. DESU's DURASHEET is a suturable dural graft matrix that can be used on both surfaces, and DECOLL is a collagen dura membrane intended for onlay use. Both are pure Type I bovine collagen, come in four sizes and are supplied ready to use and gamma sterilized.

Reasons given for synthetics

Equally, some surgeons prefer a synthetic substitute. Reasons commonly given include a preference for a material without animal origin, particular handling characteristics, or experience with a specific product in a specific type of repair. Some patients also prefer to avoid animal-derived implants for personal, dietary or religious reasons, and a synthetic can be an option for them.

Preferences also follow training. Surgeons tend to stay with the material they learned on, and departments develop shared habits over years. That is not a weakness in decision-making; it reflects the value of predictability in a delicate step of the operation.

A distributor of collagen grafts should not argue against these preferences. A hospital with surgeons who prefer synthetics will keep buying them, and a rep who disparages them loses credibility with everyone in the room.

What should a buyer ask any supplier, regardless of material?

The most useful questions apply to both categories. They separate well-documented products from poorly documented ones, whatever the material.

• What exactly is the product made of, and how is the material characterized?
• How was biological safety evaluated, and can we see a summary against the ISO 10993 series?
• For animal-derived products, how are sourcing and TSE risk controlled, under the ISO 22442 series?
• How is the product sterilized, and what is its shelf life?
• Is it intended for sutured use, onlay use or both, according to the IFU?
• Which sizes are available, and how is it packaged and labeled?
• Who manufactures it, under what quality system, and how quickly can they answer technical questions?
• How reliable is supply, and what happens if there is a shortage?

DESU can answer these questions for its collagen grafts with documentation, and a credible synthetic supplier should be able to do the same for theirs.

Does the hospital need both categories?

Many hospitals stock at least one collagen and one synthetic option, or a collagen graft alongside autologous tissue. The reasons are practical: different surgeons have different preferences, some patients decline animal-derived implants, and a second source protects against supply interruptions.

What about cost?

Cost comparisons between categories are difficult to make in general terms, because prices vary by product, size, contract and region. A committee should compare the specific products it is considering, at its own contracted prices, and include the practical costs around them: the sizes needed, waste from trimming or expiry, and the time staff spend managing additional items. A supplier who offers a sensible size range and reliable supply can reduce some of those hidden costs, whichever category the product belongs to.

The question for a value-analysis committee is not "which category wins?" but "which products do our surgeons need, and how many items can we sensibly hold?" A clear, technique-based rationale for each item on the shelf, such as one sutured collagen graft, one onlay collagen graft and one synthetic, is easier to defend than a shelf of overlapping products added one request at a time.

How should the comparison be presented to a committee?

A committee responds well to a short, neutral comparison followed by a clear request. A format that works:

• One slide or page describing the two categories in neutral terms, like the table above.
• The surgeon's reason for wanting the specific product.
• The product's documentation, summarized in a few lines.
• The supply details: sizes, packaging, lead time, and the contact for questions.
• How the product would sit alongside what the hospital already stocks.

Avoid comparative claims about outcomes unless there is published evidence directly addressing the products concerned. A committee that senses a sales pitch will become cautious; one that sees a fair comparison will focus on the merits.

Where does DESU fit?

DESU represents the collagen category, with two products that map to the two main techniques. The company was founded in 2007 at Hacettepe Teknokent in Ankara, Türkiye, manufactures in its own cleanrooms under an ISO 13485 quality system, carries the CE mark on its products and exports to more than 50 countries. For buyers, that means a manufacturer that can answer technical questions directly and supply the documentation a fair comparison requires.

For distributors, the message is equally simple. A collagen line from DESU does not need to displace synthetics to be worth carrying. It needs to serve the surgeons who prefer collagen, in the techniques they use, with documentation that stands up to scrutiny and supply that arrives when promised. Our article on type I bovine collagen for value-analysis committees covers the material in more depth.

Talk to a DESU product specialist

If you are comparing dural substitutes for a hospital or building a balanced dural graft portfolio as a distributor, DESU's product specialists can provide documentation for DURASHEET and DECOLL and discuss the requirements of your market. Write to sales@desu.tr, use the contact page, or request a quote.